Trial data catalysts: how stocks trade on clinical readouts
Clinical and trial readouts that moved a stock 10% or more: the minute each crossed, how the chart traded around it session by session, and how LiveChart’s stack read every turn.
Only trial data, newest sessions first. All kinds
Tuesday, November 17, 20261 reaction · 1 up · 0 down
Tuesday, November 10, 20261 reaction · 1 up · 0 down
Monday, November 9, 20262 reactions · 0 up · 2 down
- Nov 97:00 AM ETFTH−42.5%Faeth Therapeutics (FTH): Phase 2 data, a 42.5% drop and what followedFTH closed −42% on Nov 9 after its Phase 2 data. Every turn in ET, read by LiveChart’s stack, with the filings.Trial data10.6× avg volume
- Nov 97:00 AM ETZURA−69.7%Zura Bio (ZURA): Phase 2 data, a 69.7% drop and what followedZURA closed −70% on Nov 9 after its Phase 2 data. Every turn in ET, read by LiveChart’s stack, with the filings.Trial data12.5× avg volume
Wednesday, November 4, 20261 reaction · 1 up · 0 down
Catalyst ScorecardIntraday MoversPremarket MoversAfter-Hours MoversAbout Catalyst ReactionsMarket Pulse
General market information from company releases, SEC filings, session prices and LiveChart’s reads. Each reaction describes what happened and when, infers no cause, takes no view on what comes next and is not a recommendation to buy or sell any security. Past reactions don’t predict future ones. Read the Risk Disclosure.